ASSET | DATE | % RETURN |
---|---|---|
P3 Health Partners (PIII) | 4/1/2023 - 5/30/2023 | 270.18% |
Corvus Pharmaceuticals (CRVS) | 4/1/2023 - 5/30/2023 | 251.14% |
Bioventus (BVS) | 4/1/2023 - 5/30/2023 | 166.97% |
Verastem (VSTM) | 4/1/2023 - 5/30/2023 | 147.62% |
Ads Tec Energy (ADSE) | 4/1/2023 - 5/30/2023 | 128.41% |
National CineMedia (NCMI) | 4/1/2023 - 5/30/2023 | 118.89% |
Bit Digital (BTBT) | 4/1/2023 - 5/30/2023 | 112.34% |
Eyepoint Pharmaceuticals (EYPT) | 4/1/2023 - 5/30/2023 | 99.32% |
American Coastal Insurance (ACIC) | 4/1/2023 - 5/30/2023 | 86.6% |
Kopin (KOPN) | 4/1/2023 - 5/30/2023 | 86.24% |
Evolv Technologies (EVLV) | 4/1/2023 - 5/30/2023 | 81.55% |
DiaMedica Therapeutics (DMAC) | 4/1/2023 - 5/30/2023 | 81.29% |
Organogenesis (ORGO) | 4/1/2023 - 5/30/2023 | 80.95% |
Sana Biotechnology (SANA) | 4/1/2023 - 5/30/2023 | 80.12% |
Aquestive Therapeutics (AQST) | 4/1/2023 - 5/30/2023 | 79.13% |
SEALSQ (LAES) | 4/1/2023 - 5/30/2023 | 74.53% |
Pulse Biosciences (PLSE) | 4/1/2023 - 5/30/2023 | 74.05% |
Autolus Therapeutics (AUTL) | 4/1/2023 - 5/30/2023 | 71.66% |
Arteris (AIP) | 4/1/2023 - 5/30/2023 | 71.63% |
Ikena Oncology (IKNA) | 4/1/2023 - 5/30/2023 | 71.6% |
MiMedx (MDXG) | 4/1/2023 - 5/30/2023 | 69.71% |
Y mAbs Therapeutics (YMAB) | 4/1/2023 - 5/30/2023 | 67.95% |
Microvision (MVIS) | 4/1/2023 - 5/30/2023 | 67.04% |
Akebia Ther (AKBA) | 4/1/2023 - 5/30/2023 | 66.95% |
WW International, Inc Common Stock (WW) | 4/1/2023 - 5/30/2023 | 63.17% |